Your browser doesn't support javascript.
loading
Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.
Kreuzinger, Caroline; Gamperl, Magdalena; Wolf, Andrea; Heinze, Georg; Geroldinger, Angelika; Lambrechts, Diether; Boeckx, Bram; Smeets, Dominiek; Horvat, Reinhard; Aust, Stefanie; Hamilton, Gerhard; Zeillinger, Robert; Cacsire Castillo-Tong, Dan.
Afiliação
  • Kreuzinger C; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria.
  • Gamperl M; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria.
  • Wolf A; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria.
  • Heinze G; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Geroldinger A; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Lambrechts D; Vesalius Research Center, VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Boeckx B; Vesalius Research Center, VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Smeets D; Vesalius Research Center, VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Horvat R; Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
  • Aust S; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria.
  • Hamilton G; Ludwig Boltzmann Cluster of Translational Oncology, Vienna, Austria.
  • Zeillinger R; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria; Ludwig Boltzmann Cluster of Translational Oncology, Vienna, Austria.
  • Cacsire Castillo-Tong D; Molecular Oncology Group, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 5Q, A-1090 Vienna, Austria. Electronic address: dan.cacsire-castillo@meduniwien.ac.at.
Cancer Lett ; 362(2): 218-28, 2015 Jul 01.
Article em En | MEDLINE | ID: mdl-25862976
ABSTRACT
Cancer cell lines are good in vitro models to study molecular mechanisms underlying chemoresistance and cancer recurrence. Recent works have demonstrated that most of the available ovarian cancer cell lines are most unlikely high grade serous (HGSOC), the major type of epithelial ovarian cancer. We aimed at establishing well characterized HGSOC cell lines, which can be used as optimal models for ovarian cancer research. We successfully established seven cell lines from HGSOC and provided the major genomic alterations and the transcriptomic landscapes of them. They exhibited different gene expression patterns in the key pathways involved in cancer resistance. Each cell line harbored a unique TP53 mutation as their corresponding tumors and expressed cytokeratins 8/18/19 and EpCAM. Two matched lines were established from the same patient, one at diagnosis and being sensitive to carboplatin and the other during chemotherapy and being resistant. Two cell lines presented respective BRCA1 and BRCA2 mutations. To conclude, we have established seven cell lines and well characterized them at genomic and transcriptomic levels. They are optimal models to investigate the molecular mechanisms underlying the progression, chemo resistance and recurrence of HGSOC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Linhagem Celular Tumoral / Mutação Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Linhagem Celular Tumoral / Mutação Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article